Other Memberships/Affiliations
Palestinian Forum for Medical Research
Degrees:
2012
Doctorate Structural, Cell and Molecular Biology
Publications resulting from Research
• Sana G, Madigan JP, Gartner JJ, Fourrez M, Lin J, Qutob N, Narayan J, Shukla S, Ambudkar SV, Xia D, Rosenberg SA, Gottesman MM, Samuels Y, Gillet JP. Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities. J Invest Dermatol. 2019 Sep;139(9):1985-1992
• Kalaora S, Wolf Y, Feferman T, Barnea E, Greenstein E, Reshef D, Tirosh I, Reuben A, Patkar S, Levy R, Quinkhardt J, Omokoko T, Qutob N, Golani O, Zhang J, Mao X, Song X, Bernatchez C, Haymaker C, Forget MA, Creasy C, Greenberg P, Carter BW, Cooper ZA, Rosenberg SA, Lotem M, Sahin U, Shakhar G, Ruppin E, Wargo JA, Friedman N, Admon A, Samuels Y. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma. (2018). Cancer Discov. 8(11):1366-1375.
• Alon M, Emmanuel R, Qutob N, Bakhman A, Peshti V, Brodezki A, Bassan D, Kosloff M, Samuels Y. Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma. (2018) Pigment Cell Melanoma Res. 31(5):641-648.
• Yu Y, Schleich K, Yue B, Ji S, Lohneis P, Kemper K, Silvis MR, Qutob N, van Rooijen E, Werner-Klein M, Li L, Dhawan D, Meierjohann S, Reimann M, Elkahloun A, Treitschke S, Dörken B, Speck C, Mallette FA, Zon LI, Holmen SL, Peeper DS, Samuels Y, Schmitt CA, Lee S. (2018). Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. Cancer Cell. 33(4).
• Qutob, N; Masuho, I; Alon, M; Emmanuel, R; Cohen, I; Di Pizio, A; Madore, J; Elkahloun, A; Ziv, T; Levy, R; Gartner, JJ; Hill, VK; Lin, JC; Hevroni, Y; Greenberg, P; Brodezki, A; Rosenberg, SA; Kosloff, M; Hayward, NK; Admon, A; Niv MY; Scolyer, RA; Martemyanov, KA; Samuels, Y; (2018) RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells. Scientific Reports, 8:653.
• Kalaora, S; E, Barnea; E, Merhavi-Shoham, N ; N, Qutob, N, Teer; N, Shimony; J, Schachter; S.A, Rosenberg; M.J, Besser; A, Admon; Y, Samuels; (2016) Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget, 7(5):5110-7.
• Levin, L1; Srour, S; Gartner, J; Kapitansky, O; Qutob, N; Dror, S; Golan, T; Dayan, R; Brener, R; Ziv, T; Khaled, M; Schueler-Furman, O; Samuels, Y; Levy, C; (2016) Parkin Somatic Mutations Link Melanoma and Parkinson's Disease. Journal of Genetics and Genomics, 43(6):369-79.
• R Inzelberg, Y Samuels, E Azizi, N Qutob, L Inzelberg. (2016). Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma. Neurology Genetics, 2 (3), e70.
• Arafeh, R; Qutob, N; Emmanuel, R1; Keren-Paz, A; Madore, J; Elkahloun, A; Wilmott, JS; Gartner, JJ; Di Pizio, A; Winograd-Katz, S; Sindiri, S; Rotkopf, R; Dutton-Regester, K; Johansson, P; Pritchard, AL; Waddell, N; Hill, VK; Lin, JC; Hevroni, Y; Rosenberg, SA; Khan, J; Ben-Dor, S; Niv, MY; Ulitsky, I; Mann, GJ; Scolyer, RA; Hayward, NK; Samuels, Y; (2015) Recurrent inactivating RASA2 mutations in melanoma. Nature Genetics, 47(12):1408-1410.
• R Emmanuel, N Qutob, V Peshti, D Bassan, Y Samuels. (2015). Use of the Endogenous Epitope Tagging approach to study melanoma driver genes. Pigment Cell & Melanoma Research. 28(6):769.
• Valer Gotea, Jared J. Gartner, Nouar Qutob, Laura Elnitski,and Yardena Samuels.(2015). The functional relevance of somatic synonymous mutations in melanoma and other cancers. Pigment Cell Melanoma Res. 28(6): 673–684.
• Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK and Samuels Y. A highly recurrent RPS27 5’UTR mutation in melanoma. (2014). Oncotarget. 5(10): 2912-2917.
• Prickett TD, Zerlanko BJ, Hill VK, Gartner JJ, Qutob N, Jiang J, Wunderlich J, Gutkind JS, Rosenberg SA and Samuels Y. Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation. (2014). J Invest Dernatol, 134.
• Qutob N, Balloux F, Raj T, Liu H, Marion de Proce M, Trowsdale J and Manica A. (2012). Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics. 64(3):165-175.
• Kalaora S, Wolf Y, Feferman T, Barnea E, Greenstein E, Reshef D, Tirosh I, Reuben A, Patkar S, Levy R, Quinkhardt J, Omokoko T, Qutob N, Golani O, Zhang J, Mao X, Song X, Bernatchez C, Haymaker C, Forget MA, Creasy C, Greenberg P, Carter BW, Cooper ZA, Rosenberg SA, Lotem M, Sahin U, Shakhar G, Ruppin E, Wargo JA, Friedman N, Admon A, Samuels Y. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma. (2018). Cancer Discov. 8(11):1366-1375.
• Alon M, Emmanuel R, Qutob N, Bakhman A, Peshti V, Brodezki A, Bassan D, Kosloff M, Samuels Y. Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma. (2018) Pigment Cell Melanoma Res. 31(5):641-648.
• Yu Y, Schleich K, Yue B, Ji S, Lohneis P, Kemper K, Silvis MR, Qutob N, van Rooijen E, Werner-Klein M, Li L, Dhawan D, Meierjohann S, Reimann M, Elkahloun A, Treitschke S, Dörken B, Speck C, Mallette FA, Zon LI, Holmen SL, Peeper DS, Samuels Y, Schmitt CA, Lee S. (2018). Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. Cancer Cell. 33(4).
• Qutob, N; Masuho, I; Alon, M; Emmanuel, R; Cohen, I; Di Pizio, A; Madore, J; Elkahloun, A; Ziv, T; Levy, R; Gartner, JJ; Hill, VK; Lin, JC; Hevroni, Y; Greenberg, P; Brodezki, A; Rosenberg, SA; Kosloff, M; Hayward, NK; Admon, A; Niv MY; Scolyer, RA; Martemyanov, KA; Samuels, Y; (2018) RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells. Scientific Reports, 8:653.
• Kalaora, S; E, Barnea; E, Merhavi-Shoham, N ; N, Qutob, N, Teer; N, Shimony; J, Schachter; S.A, Rosenberg; M.J, Besser; A, Admon; Y, Samuels; (2016) Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget, 7(5):5110-7.
• Levin, L1; Srour, S; Gartner, J; Kapitansky, O; Qutob, N; Dror, S; Golan, T; Dayan, R; Brener, R; Ziv, T; Khaled, M; Schueler-Furman, O; Samuels, Y; Levy, C; (2016) Parkin Somatic Mutations Link Melanoma and Parkinson's Disease. Journal of Genetics and Genomics, 43(6):369-79.
• R Inzelberg, Y Samuels, E Azizi, N Qutob, L Inzelberg. (2016). Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma. Neurology Genetics, 2 (3), e70.
• Arafeh, R; Qutob, N; Emmanuel, R1; Keren-Paz, A; Madore, J; Elkahloun, A; Wilmott, JS; Gartner, JJ; Di Pizio, A; Winograd-Katz, S; Sindiri, S; Rotkopf, R; Dutton-Regester, K; Johansson, P; Pritchard, AL; Waddell, N; Hill, VK; Lin, JC; Hevroni, Y; Rosenberg, SA; Khan, J; Ben-Dor, S; Niv, MY; Ulitsky, I; Mann, GJ; Scolyer, RA; Hayward, NK; Samuels, Y; (2015) Recurrent inactivating RASA2 mutations in melanoma. Nature Genetics, 47(12):1408-1410.
• R Emmanuel, N Qutob, V Peshti, D Bassan, Y Samuels. (2015). Use of the Endogenous Epitope Tagging approach to study melanoma driver genes. Pigment Cell & Melanoma Research. 28(6):769.
• Valer Gotea, Jared J. Gartner, Nouar Qutob, Laura Elnitski,and Yardena Samuels.(2015). The functional relevance of somatic synonymous mutations in melanoma and other cancers. Pigment Cell Melanoma Res. 28(6): 673–684.
• Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK and Samuels Y. A highly recurrent RPS27 5’UTR mutation in melanoma. (2014). Oncotarget. 5(10): 2912-2917.
• Prickett TD, Zerlanko BJ, Hill VK, Gartner JJ, Qutob N, Jiang J, Wunderlich J, Gutkind JS, Rosenberg SA and Samuels Y. Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation. (2014). J Invest Dernatol, 134.
• Qutob N, Balloux F, Raj T, Liu H, Marion de Proce M, Trowsdale J and Manica A. (2012). Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics. 64(3):165-175.